As one of the nation's leading comprehensive medical schools, Robert Wood Johnson Medical School is known for creating new therapies and developing landmark treatments that shape the future of medicine
Robert Wood Johnson Medical School physicians have received federal, state, and local funding to pursue research in a wide range of clinical areas, including cystic fibrosis, lupus, chronic Lyme disease, cardiac disease, and scleroderma. At the Cancer Institute of New Jersey—the state's only National Cancer Institute–designated Comprehensive Cancer Center—researchers have pioneered breakthrough methods to target cancer with radioactive therapy and are able to provide access to clinical trials not available at other hospitals, clinics, or doctor's offices.
Discover more about the current clinical trials under way.
Robert Wood Johnson Medical School Clinical Trials
The medical school's mission includes the support, advancement, and promotion of clinical and translational research enterprises. Learn more about the clinical trial process, view clinical researcher profiles, as well as search for active trials for a condition of interest to you.
Cancer Institute of New Jersey
Cancer Institute of New Jersey offers patients access to treatment options not available at other institutions within the state. Committed to improving the current knowledge and promoting overall reductions in cancer incidence, the institute currently enrolls more than 3,000 patients in clinical trials annually. Its network combines the strengths and skills of the state's expert providers to improve the progress of research, education, and cancer prevention throughout the state.
Learn more—including a searchable database of available clinical trials for cancer.